MAINZ BIOMED B V's ticker is and the CUSIP is N5436L101. A total of 9 filers reported holding MAINZ BIOMED B V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $478 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenwich Investment Management, Inc. | 13,909 | $41,000 | 0.03% |
| UBS Group AG | 98 | $286 | 0.00% |
| NewEdge Advisors, LLC | 1,000 | $2,920 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200 | $584 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 673 | $1,965 | 0.00% |
| MORGAN STANLEY | 200 | $584 | 0.00% |
| Steward Partners Investment Advisory, LLC | 1,500 | $4,380 | 0.00% |
| JPMORGAN CHASE & CO | 2,569 | $7,501 | 0.00% |